Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19239128 | 0.83 | CA2 (0.40) | ALDH1A1HPGD | |
| SCHEMBL30196676 | 0.79 | GPR3 (0.54) | ALDH1A1MAPTHPGDRAB9ASMN1; SMN2 | |
| SCHEMBL8672690 | 0.79 | GPR3 (0.54) | ALDH1A1MAPTHPGDRAB9ASMN1; SMN2 | |
| SCHEMBL19239050 | 0.72 | CA2 (0.44) | ALDH1A1MAPTHPGDRAB9ASMN1; SMN2 | |
| SCHEMBL13520157 | 0.72 | TRPA1 (0.32) | ALDH1A1 | |
| SCHEMBL10018350 | 0.72 | PIM1 (0.35) | ALDH1A1MAPTRAB9A | |
| SCHEMBL19274923 | 0.69 | ESR1 (0.38) | ALDH1A1MAPTHPGDRAB9ASMN1; SMN2 | |
| SCHEMBL23691950 | 0.67 | HPGD (0.38) | ALDH1A1MAPTHPGDRAB9ASMN1; SMN2 | |
| SCHEMBL28796955 | 0.67 | EPM2A (0.39) | ALDH1A1MAPTHPGDRAB9ASMN1; SMN2 | |
| SCHEMBL1041547 | 0.67 | KDM4E (0.58) | ALDH1A1MAPTHPGDRAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180151806-A2 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2018-05-31 | — | — | US | disclosed |
| US-20170237013-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2017-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170237013-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | EML4, EBPL, NFE2L2 | ALDH1A1 1021/4885MAPT 881/4885HPGD 3558/4885 |
| US-20180151806-A2 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | EBPL, EML4, NFE2L2 | ALDH1A1 919/4885MAPT 975/4885HPGD 3851/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.